mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3- mutated acute myeloid leukemia cells

Weina Chen(Army Medical University), George Z. Rassidakis(Karolinska University Hospital)

Molecular Cancer

November 10, 2010

10.1186/1476-4598-9-292

Cited by 105

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|677

NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma

|Blood|2007|83

Prognostic Factors of Hepatosplenic T-cell Lymphoma

|The American Journal of Surgical Pathology|2016|82

Simple karyotype and bcl-6 expression predict a diagnosis of Burkitt lymphoma and better survival in IG-MYC rearranged high-grade B-cell lymphomas

|Modern Pathology|2010|61

miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT

|PLoS ONE|2015|27